Chief Financial Officer · Passage BIO, Inc. (PASG)

Kathleen Borthwick

A named executive officer of Passage BIO in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$851,839

Salary $450,627Stock awards $117,020

FY2024: $861,698

2nd of 3 named executive officers at Passage BIO by FY2025 total.

3 named officers on file for Passage BIO, FY2025

Kathleen Borthwick’s pay file — $29

  • 2 fiscal years of pay, line by line
  • PASG’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Passage BIO’s whole pay program stands against its peers

  • Passage BIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PASG→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 7, 2026 (DEF 14A).

Free

Get Kathleen Borthwick’s full pay file as a PDF — free

More than this page: up to 10 years of Kathleen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Kathleen Borthwick compensation by year

Passage BIO Summary Compensation Table · all 2 fiscal years held
In US dollars, as Passage BIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$420,692$450,627
Bonus$0—
Stock awards$0$117,020
Option awards$256,971$85,440
Non-equity incentive$166,785$181,252
Pension and deferred compensation$0—
All other$17,250$17,500
Total$861,698$851,839

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Passage BIO, Inc. DEF 14A filed April 7, 2026, accession 0001104659-26-040130, and prior-year filings.

How this page was built: the Passage BIO, Inc. filed document, accession 0001104659-26-040130. Every figure is read from that document and cited to the page and table it appears in. Filed April 7, 2026.

$862K
$852K
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU10,000$118,000—
Option6,384—$30.00
Option856—$21.60
Option395—$17.55
Option11,308—$7.74

Per the Outstanding Equity Awards at Fiscal Year-End table in Passage BIO, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Passage BIO’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
William ChouPresident, Chief Executive Officer and Director$1,486,763
Kathleen Borthwick · this pageChief Financial Officer$851,839
Edgar CaleGeneral Counsel and Corporate Secretary$593,290

The full Passage BIO compensation record

free company brief

This page is one person within Passage BIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Passage BIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kathleen Borthwick's compensation dossier · One-time report. No refunds.